Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent

…, CHP Jansen, E Nagel, R Razavi, DC Onthank… - Nature medicine, 2011 - nature.com
Atherosclerosis and its consequences remain the main cause of mortality in industrialized and
developing nations. Plaque burden and progression have been shown to be independent …

Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis

…, R Weiskirchen, DC Onthank… - Science translational …, 2019 - science.org
Fibrosis is the common endpoint and currently the best predictor of progression of chronic
kidney diseases (CKDs). Despite several drawbacks, biopsies remain the only available …

Concurrent molecular magnetic resonance imaging of inflammatory activity and extracellular matrix degradation for the prediction of aneurysm rupture

…, DC Onthank, C Thöne-Reineke… - Circulation …, 2019 - Am Heart Assoc
Background: Molecular magnetic resonance imaging is a promising modality for the
characterization of abdominal aortic aneurysms (AAAs). The combination of different molecular …

In vivo assessment of aortic aneurysm wall integrity using elastin-specific molecular magnetic resonance imaging

…, A Warley, CHP Jansen, DC Onthank… - Circulation …, 2014 - Am Heart Assoc
Background— The incidence of abdominal aortic aneurysms (AAAs) has increased during
the last decades. However, there is still controversy about the management of medium-sized …

Assessment of myocardial infarction and postinfarction scar remodeling with an elastin-specific magnetic resonance agent

…, A Feuchtinger, M Settles, DC Onthank… - Circulation …, 2014 - Am Heart Assoc
Background— To prospectively evaluate an elastin-specific MR contrast agent (ESMA) for
in vivo targeting of elastic fibers in myocardial infarction (MI) and postinfarction scar …

90Y and 111In Complexes of a DOTA-Conjugated Integrin αvβ3 Receptor Antagonist:  Different but Biologically Equivalent

DC Onthank, S Liu, PJ Silva, JA Barrett… - Bioconjugate …, 2004 - ACS Publications
90 Y-TA138 is a 90 Y-labeled nonpeptide integrin α v β 3 receptor antagonist that binds with
high affinity and specificity to integrin α v β 3 receptors overexpressed on both endothelial …

Vascular remodeling and plaque vulnerability in a rabbit model of atherosclerosis: comparison of delayed-enhancement MR imaging with an elastin-specific contrast …

A Phinikaridou, ME Andia, A Indermuehle, DC Onthank… - Radiology, 2014 - pubs.rsna.org
Purpose To compare delayed-enhancement (DE) magnetic resonance (MR) imaging with an
elastin-specific contrast agent and unenhanced black-blood (BB) MR imaging with regard …

Three-dimensional imaging of the aortic vessel wall using an elastin-specific magnetic resonance contrast agent

…, A Keithan, RR Cesati, DC Onthank… - Investigative …, 2012 - journals.lww.com
Objective The aim of this study was to demonstrate the feasibility of high-resolution 3-dimensional
aortic vessel wall imaging using a novel elastin-specific magnetic resonance contrast …

[HTML][HTML] Dual-probe molecular MRI for the in vivo characterization of atherosclerosis in a mouse model: Simultaneous assessment of plaque inflammation and …

…, LC Adams, DC Onthank, C Thöne-Reineke… - Scientific reports, 2019 - nature.com
Molecular MRI is a promising in-vivo modality to detect and quantify morphological and
molecular vessel-wall changes in atherosclerosis. The combination of different molecular …

Assessment of elastin deficit in a Marfan mouse aneurysm model using an elastin-specific magnetic resonance imaging contrast agent

…, BA Dake, M Arakawa, DC Onthank… - Circulation …, 2014 - Am Heart Assoc
Background— Ascending aortic dissection and rupture remain a life-threatening complication
in patients with Marfan syndrome. The extracellular matrix provides strength and elastic …